Med-X, Inc. is in live offering mode and is actively accepting Title IV investments.
$420.00 minimum investment

Med-X, Inc.

Educate, Innovate, Cultivate

Large OPO
Canoga Park, CA
Agriculture
Accepting International Investment
Play video

Med-X innovates all-natural and alternative solutions to everyday problems. Currently, Med-X products provide effective nontoxic and 100% all-natural pest management products to cannabis cultivators. These same products are currently used widely in the pest control, hospitality and janitorial arenas nationally.


The Marijuana Times, the media division of Med-X, publishes original content aimed at educating the cannabis community on the medicine, the science, and the world of the cannabis industry. With an all-star management team and experienced doctors at the helm, Med-X is blazing the trail of the green scene with products aimed at helping people to live better lives.

Inform the public through a digital magazine.


Through The Marijuana Times digital magazine, Med-X aims to educate and provide thoughtful and engaging articles and facts about and for the cannabis community.

Introduce all-natural products for cultivation.


Med-X innovates, researches, and develops a variety of natural products that provide safe alternatives to consumers. One Med-X exclusively licensed product "Nature-Cide Insecticides" are being marketed to cannabis cultivators nationally.

Research and grow medicinal cannabis for testing.


With patient care in mind first, Med-X's cultivation lab conducts research and grows medicinal cannabis in various potencies for testing. We aim to ensure that cannabis grown for medical or recreational use is as safe as possible.

We innovate the everyday. The Med-X management team has built a cannabis company that focuses on ancillary products, research and development, and education.


Med-X is focusing on medical applications where real results are coming out of extensive research. Innovation begins with the doctors, scientists, and the experienced management team working together to bring products that impact people’s lives in positive ways.


As the legalization of medical and recreational cannabis continues to spread across the country, Med-X is prepared for the unprecedented, explosive growth of the industry by cultivating excellence across three divisions, Media, Cultivation Pest Control and Research & Development.

The legalization of recreational/medical cannabis is taking over the United States. Multiple states have seen massive tax gains from legalizing recreational use while medical system states continue to be a model for other states around the country. More than half of the states in the US have some medical marijuana legislation.

As more states legalize medical and recreational cannabis, the demand for Med-X's quality products is growing. Innovation is where Med-X excels,

and Med-X consumer-ready products support the expansion of the industry.

State by state, new requirements for contaminant testing and product potency are affecting cultivators who handle pests and molds with harmful and toxic treatments of the past. As laws remove harmful and poisonous pesticides from the cultivation facilities and require nontoxic treatments, Nature-Cide is positioned to become an industry standard for organic pest control management.


Until the industry receives federal recognition and official legislation, patients, and cannabis users are exposed to products that have been cultivated using the ways of the past and by cultivators interested inquantity over quality. Until there is a federal regulatory body for medical cannabis, patients, and recreational users have no way to know where their product comes from or whether or not it was treated with toxic pest repellents. Patients using strains that have been treated with Med-X’s Nature-Cide green pest-control products will know their medicine is safe, even without a government stamp.


The cannabis industry has tremendous potential and our products are ready for cultivators who are looking to meet growing demand. With the commercial pest control, hospitality and janitorial venues using and recommending Nature-Cide nationally, Med-X has created a perfect jump-off point into cannabis cultivation. Management's track record with product development coupled with multiple national distribution relationships presents the opportunity for success.

Now is a great time to consider investing in Med-X as we are positioned to embrace and benefit from the booming cannabis industry. Ballots are heating up with cannabis laws, new businesses are sprouting up to provide products and supplies, and we believe we have the tools to capitalize on the massive growth of the cannabis industry. Make history with us and indicate your interest in Med-X as we take this industry by storm. Thanks to the rapid growth of the cannabis industry, new trends have developed to better support this growth.

Multi-state licensing is crucial to national cannabis brands finding lasting success. States are beginning to require product potency and contaminant testing to ensure consumer safety, and new laboratories are emerging to meet these needs. In 2017 Med-X released a Pest Control Cultivation Report.


2017 Nature-Cide Cannabis Cultivation Report


The landscape of cultivation is changing as licensed facilities grow in size and numbers to meet the booming medical and recreational demand for cannabis.

Cannabis cultivation materials, supplies, and medical research are deemed to grow into billion dollar industries on their own in a matter of years.

Our media magazine, The Marijuana Times, will draw advertisers and partners to this space in a market where many outlets block the promotion of cannabis related ads.

Our research and development of medical grade strains and potencies will play a long-term role in the business model and eventually distribute cannabis to the medical community.

Med-X is poised to compete in the market with a tested and proven green alternative to pest control, that will meet the new state licensing standards. Cultivation centers and growers will be required to follow guidelines to deploy products such as Nature-Cide Insecticides.

The industry is expanding. We have the right products, the right timing, and the right team in place to maximize our impact. We are first in the cannabis sector to bring this opportunity to the people.

Disrupting an industry, educating the public, and providing safe, effective patient care is our mission. We are working to make the world a better place through each and every division of our company. And that is why we are going to be a smart investment.

We are scientists, doctors, and passionate business professionals who want to help the world and provide cleaner, safer, and more effective ways to reap the many benefits of medical cannabis.


Med-X, Inc. is already working on various stages of automation that will change the cannabis market forever and you can be a part of it today.

All Economic Value details, including future projections, employment numbers and or statistics, are sourced from The Marijuana Business Fact Book. Produced by the Marijuana Business Daily. Industry and revenue statistics are sourced from the ArcView Market Research Report.


What is Reg A+ Equity Crowdfunding?


In June 2015, the final Regulation A+ rules under Title IV of the JOBS Act of 2012 became effective, after approval by the Securities and Exchange Commission, paving the way for companies like Med-X, Inc. to raise up to $50 million from both accredited and non-accredited investors.


Med-X, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA).


THE SECURITIES OFFERED HEREBY ARE HIGHLY SPECULATIVE. INVESTING IN SHARES OF MED-X, INC. INVOLVES SIGNIFICANT RISKS.


THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT THEIR INVESTMENT IN MED-X, INC. COULD BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET CURRENTLY EXISTS FOR THE SECURITIES AND IF A PUBLIC MARKET DEVELOPS FOLLOWING THIS OFFERING IT MAY NOT CONTINUE.


MED-X, INC. 8236 REMMET AVENUE CANOGA PARK, CA 91304 - YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.

VIEW OFFERING CIRCULAR HERE


THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, MED-X, INC., ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO MED-X, INC.’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. MED-X, INC. DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

Updates

StartEngine Live Offering FAQs

over 1 year ago

MED-X, INC. 


Is there a cost to investing?

No, there is no fee charged to the investor at any point during or after the transaction incurred from the StartEngine platform. You pay only for the number of shares you desire to purchase. However, some banks do charge for wire transfers or international transfers.

 

Do I have an account?

If you made a reservation for shares, then you do have a StartEngine account as one is required to make a reservation. If you no longer remember the password, you can recover it by going to www.startengine.com/forgot-password and entering the email address associated with your StartEngine account. If you did not make a reservation for shares, you will need to create a StartEngine account.

 

I forgot my password, what do I do?

You can recover your password by going to www.startengine.com/forgot-password and entering your email address.  An email with a link allowing you to reset your password and login will be sent to the email address you entered. Click on the link and follow the instructions to reset your password.  If you do not see the reset password email, please check your spam folder to make sure it did not get caught by the spam filter. If you still do not get the email, please contact customer experience at
contact@StartEngine.com.

**Please note if you try to recover your password but have not set up a StartEngine account, you will not receive an email.** 


Who can invest?

Anyone can invest. In a departure from previous investment rules, the SEC now permits Regulation A (also called Reg A+) offerings to take on investors who are non-accredited as well as accredited investors.  An accredited investor is an individual who has a net worth in excess of $1MM (excluding his or her primary residence) or has had an annual income in excess of $200,000 ($300,000 if joint income) for the past two years and reasonably expects that to continue. If you are a non-accredited investor, you may invest but will be limited to investing no more than the greater of 10% of your net worth or 10% of your annual income.


Do I have to invest a specific amount?

No, you may invest any amount as long as you meet the minimum investment amount of $420 AND, if you are a non-accredited investor, the amount you invest does not exceed the greater of 10% of your net worth or 10% of your annual income.  


How much is the minimum investment?

The minimum investment amount for MED-X, INC. is $420 or 700 shares.


What is the price per share?

The price per share for the MED-X, INC. offering is $0.60 per share.


Where can I get the full financial details on the offering?

Please refer to the Offering Circular for information on the offering.  


Can I invest by writing a check?

No, we are not accepting paper checks. Please use the Automated Clearing House (ACH) transfer or wire transfer options which are integrated with the StartEngine platform.


Is using StartEngine the only way to invest in MED-X, INC.’s Reg A+ offering?

Yes, you can only purchase Reg A+ shares in MED-X, INC. through the StartEngine platform.


Can I cancel my investment?

Yes, you can cancel your investment. If you made a mistake, you will have a 24-business hour window to contact live customer service via chat to correct your submission or cancel. 

Live chat customer service hours are as follows:

Saturday - Sunday: closed

Monday - Friday 12pm-8pm EST (9am-5pm PST) 

 

What documentation/confirmation will I receive for my investment?

Investors will receive a confirmation of their investment and a subscription agreement that has been accepted by MED-X, INC. via email.

 

Who is FundAmerica and why are they involved?

MED-X, INC. will use FundAmerica Securities, an SEC registered, FINRA member and SIPC insured broker-dealer to oversee and administer the actual financial transactions to comply with state and federal regulatory requirements.


How will I know when my investment funds have been deducted from my account?

Once FundAmerica has processed the investment, funds will be deducted via ACH or through a wire transfer. Your bank account should show a payment to FundAmerica / Alliance Bank.

 

Help, I’m experiencing a problem or having trouble using the platform to invest!

For assistance with making your investment, please contact StartEngine customer support via email at contact@startengine.com, live chat on our website by clicking on the green chat widget in the lower right corner.